|
⚲
|
| Keyboard |
| Rock Springs Capital LLC
✚
|
|
|---|---|
| CIK # | 0001595725, 0001735397 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Revolution Medicines Inc | 0.1 | ||
| Lilly Eli & Co | 0.1 | ||
| Synta Pharmaceuticals Corp | 0.1 | ||
| Mirum Pharmaceuticals Inc | 0.1 | ||
| Argenx SE | 0.1 | ||
| Rhythm Pharmaceuticals Inc | 0.1 | ||
| Insmed Inc | 0.1 | ||
| Ascendis Pharma A/S | 0.0 | ||
| Xenon Pharmaceuticals Inc | 0.0 | ||
| Desert Gateway Inc | 0.0 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001595725] | |
| 3 | [0001595725] | |
| 4 | [0001595725] | |
| SC 13G | [0001595725] | |
| 3 | [0001735397] | |
| 4 | [0001735397] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Xilio Therapeutics Inc XLO
Common Stock
|
2021-10-26 | Conversion | 756,472 | ||
|
Xilio Therapeutics Inc XLO
Series C Preferred Stock · derivative
|
2021-10-26 | Conversion | 7,186,490 | ||
|
Xilio Therapeutics Inc XLO
Series C Preferred Stock · derivative
|
2021-10-26 | Conversion | 1,437,297 | ||
|
Xilio Therapeutics Inc XLO
Common Stock
|
2021-10-26 | Buy | 500,000 | $16.00 | 8,000,000 |
|
Xilio Therapeutics Inc XLO
Common Stock
|
2021-10-26 | Conversion | 151,294 | ||
|
Theseus Pharmaceuticals Inc THRX
Series B Convertible Preferred Stock · derivative
|
2021-10-12 | Conversion | 349,320 | ||
|
Theseus Pharmaceuticals Inc THRX
Common Stock
|
2021-10-12 | Buy | 250,000 | $16.00 | 4,000,000 |
|
Theseus Pharmaceuticals Inc THRX
Common Stock
|
2021-10-12 | Conversion | 87,329 | ||
|
Theseus Pharmaceuticals Inc THRX
Common Stock
|
2021-10-12 | Conversion | 349,320 | ||
|
Theseus Pharmaceuticals Inc THRX
Series B Convertible Preferred Stock · derivative
|
2021-10-12 | Conversion | 87,329 | ||
|
Verve Therapeutics Inc VERV
Common Stock
|
2021-06-21 | Conversion | 556,298 | ||
|
Verve Therapeutics Inc VERV
Common Stock
|
2021-06-21 | Buy | 370,000 | $19.00 | 7,030,000 |
|
Verve Therapeutics Inc VERV
Common Stock
|
2021-06-21 | Conversion | 152,926 | ||
|
Verve Therapeutics Inc VERV
Series B Preferred Stock · derivative
|
2021-06-21 | Conversion | 1,416,023 | ||
|
Verve Therapeutics Inc VERV
Series B Preferred Stock · derivative
|
2021-06-21 | Conversion | 5,151,043 | ||
|
Atea Pharmaceuticals Inc AVIR
Series D Convertible Preferred Stock · derivative
|
2020-11-03 | Conversion | 178,063 | ||
|
Atea Pharmaceuticals Inc AVIR
Series D-1 Convertible Preferred Stock · derivative
|
2020-11-03 | Conversion | 104,340 | ||
|
Atea Pharmaceuticals Inc AVIR
Series D Convertible Preferred Stock · derivative
|
2020-11-03 | Conversion | 890,313 | ||
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2020-11-03 | Buy | 7,292 | $24.00 | 175,008 |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2020-11-03 | Buy | 242,708 | $24.00 | 5,824,992 |
| showing 20 of 38 most recent transactions | |||||